T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 70 filers reported holding T2 BIOSYSTEMS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $97,000 | – | 36,822 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 2,374,571 | $36,853,000 | 16.46% |
Aisling Capital LLC | 2,523,300 | $39,162,000 | 5.12% |
AlpInvest Partners B.V. | 134,087 | $2,081,000 | 3.89% |
Foresite Capital Management II, LLC | 233,019 | $3,616,000 | 2.14% |
Senvest Management, LLC | 511,366 | $7,936,000 | 0.49% |
Harvest Capital Strategies LLC | 356,900 | $5,539,000 | 0.49% |
HAMILTON LANE ADVISORS LLC | 64,226 | $997,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 148,027 | $2,297,000 | 0.32% |
GILDER GAGNON HOWE & CO LLC | 1,331,826 | $20,670,000 | 0.29% |
TIGER MANAGEMENT L.L.C. | 90,909 | $1,411,000 | 0.24% |